Proceedings: Chemotherapy of soft-tissue sarcomas.
D000293:Adolescent; D000577:Amides / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy; D006394:Hemangiosarcoma / Q000188:drug therapy; D018219:Histiocytoma, Benign Fibrous / Q000188:drug therapy; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007890:Leiomyosarcoma / Q000188:drug therapy; D008080:Liposarcoma / Q000188:drug therapy; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012208:Rhabdomyosarcoma / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy*; D013584:Sarcoma, Synovial / Q000188:drug therapy; D014226:Triazenes / Q000627:therapeutic use
D000577:Amides; D000970:Antineoplastic Agents; D007093:Imidazoles; D014226:Triazenes; D003609:Dactinomycin; D003520:Cyclophosphamide; D003630:Daunorubicin